Inozyme Pharma Inc (INZY)
4.65
+0.05
(+1.09%)
USD |
NASDAQ |
May 02, 16:00
4.65
0.00 (0.00%)
After-Hours: 20:00
Inozyme Pharma Price to Book Value: 2.048 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.026 |
| April 30, 2024 | 1.942 |
| April 29, 2024 | 1.946 |
| April 26, 2024 | 1.955 |
| April 25, 2024 | 1.907 |
| April 24, 2024 | 1.937 |
| April 23, 2024 | 1.937 |
| April 22, 2024 | 1.933 |
| April 19, 2024 | 1.983 |
| April 18, 2024 | 2.014 |
| April 17, 2024 | 2.045 |
| April 16, 2024 | 2.133 |
| April 15, 2024 | 2.071 |
| April 12, 2024 | 2.260 |
| April 11, 2024 | 2.295 |
| April 10, 2024 | 2.304 |
| April 09, 2024 | 2.410 |
| April 08, 2024 | 2.581 |
| April 05, 2024 | 2.819 |
| April 04, 2024 | 2.854 |
| April 03, 2024 | 3.153 |
| April 02, 2024 | 3.047 |
| April 01, 2024 | 3.214 |
| March 28, 2024 | 3.368 |
| March 27, 2024 | 3.250 |
| Date | Value |
|---|---|
| March 26, 2024 | 2.981 |
| March 25, 2024 | 2.740 |
| March 22, 2024 | 2.550 |
| March 21, 2024 | 2.581 |
| March 20, 2024 | 2.599 |
| March 19, 2024 | 2.502 |
| March 18, 2024 | 2.638 |
| March 15, 2024 | 2.59 |
| March 14, 2024 | 2.471 |
| March 13, 2024 | 2.537 |
| March 12, 2024 | 2.515 |
| March 11, 2024 | 2.524 |
| March 08, 2024 | 2.792 |
| March 07, 2024 | 2.735 |
| March 06, 2024 | 2.647 |
| March 05, 2024 | 2.735 |
| March 04, 2024 | 2.752 |
| March 01, 2024 | 2.88 |
| February 29, 2024 | 2.796 |
| February 28, 2024 | 2.884 |
| February 27, 2024 | 3.008 |
| February 26, 2024 | 2.687 |
| February 23, 2024 | 2.511 |
| February 22, 2024 | 2.436 |
| February 21, 2024 | 2.480 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3147
Minimum
Dec 30 2022
4.127
Maximum
Jan 15 2021
2.01
Average
1.982
Median
Oct 05 2021
Price to Book Value Benchmarks
| Xeris Biopharma Holdings Inc | -- |
| Kodiak Sciences Inc | 0.7313 |
| Phathom Pharmaceuticals Inc | -- |
| Athira Pharma Inc | 0.5770 |
| Disc Medicine Inc | 2.073 |
Price to Book Value Related Metrics
| Price | 4.65 |
| Earnings Yield | -29.89% |
| Market Cap | 287.63M |